Topotecan for the treatment of recurrent and stage IVB cervical cancer

  • Technology appraisal guidance
  • TA183
  • Published: 
Download guidance (PDF)

Update information

February 2014: Implementation section updated to clarify that topotecan is recommended as an option for treating recurrent or stage IVB cervical cancer.

ISBN: 978-1-4731-7086-5